期刊文献+

血清癌抗原125与肝硬化患者肝功能损害的相关性研究 被引量:1

The research of correlation of cancer antigen 125 in serum and the impairment of hepatic function in patients with hepatic cirrhosis.
下载PDF
导出
摘要 目的研究血清癌抗原125(cancer antigen 125,CA125)和肝硬化患者肝功能损害的相关性。方法应用化学发光法测定79例肝硬化患者和58例正常体检者血清CA125的浓度。按照Child-Pugh分级标准将所有患者分为Child-Pugh A级、B级、C级三组。根据有无腹水将所有患者分为有腹水、无腹水二组。结果正常体检者血清CA125浓度为(18.12±11.45)U/ml,肝硬化患者血清CA125浓度为(337.95±193.98)U/ml,二者差异有统计学意义(P<0.001)。79例肝硬化患者中Child-Pugh A级23例、B级37例、C级19例,Child-Pugh评分分别为(3.57±1.59)、(8.35±0.86)、(10.89±1.05),血清CA125浓度分别为(148.65±89.59)、(324.84±105.85)、(592.63±127.38)U/ml。其中有腹水者41例,无腹水者38例,Child-Pugh评分分别为(9.88±1.89)、(5.08±2.28),血清CA125浓度分别为(491.07±132.55)U/ml、(172.74±79.46)U/ml。Child-Pugh B级患者血清CA125浓度较A级显著升高(P<0.001),C级患者血清CA125浓度较B级显著升高(P<0.001)。有腹水者血清CA125浓度较无腹水者显著升高(P<0.001)。肝硬化组患者血清CA125浓度升高与肝硬化Child-Pugh分级相关(r=0.841,P<0.01)。结论血清CA125与肝硬化患者肝功能损害程度相关,可作为反映肝功能损害程度的指标之一。 Objective To investigate the correlation of CA125 in serum and the impairment of hepatic function in patients with hepatic cirrhosis.Methods The levels of CA125 in serum were observed in 79 patients with hepatic cirrhosis and 58 persons without any disease.All patients were divided into 3 subgroups according to Child-Pugh's classification: Child-Pugh A,B and C.And all patients were divided into 2 subgroups according to wether suffered from ascites.Results The levels of CA125 in serum of persons without any disease was(18.12±11.45)U/ml,and the levels of CA125 in serum of patients with hepatic cirrhosis was(337.95±193.98)U/ml,there was statistical significance in the distinction(P0.001).There were 23,37 and 19 cases in Child-Pugh A,B and C grade subgroups,respectively.And the Child-Pugh's score was(3.57±1.59),(8.35±0.86)and(10.89±1.05),and the values of CA125 in serum was(148.65±89.59),(324.84±105.85) and(592.63±127.38)U/ml,correspondingly.There were 41 and 38 cases in the ascites and non-ascites subgroups,respectively.And the Child-Pugh's score was(9.88±1.89)and(5.08±2.28) and the values of CA125 in serum was(491.07±132.55)U/ml and(172.74±79.46)U/ml,correspondingly.The values of CA125 in serum in group B was more significant than group A(P0.001).The values of CA125 in serum in group C was more significant than group B(P0.001).The values of CA125in serum of patients with ascites was more significant than patients without ascites(P0.001).There was a correlation between the values of CA125 in serum and the Child-Pugh's score(r=0.841,P0.01) in patients with hepatic cirrhosis.Conclusion The levels of CA125 in serum can implicate the impairment of hepatic function and can be a marker for impairment of hepatic function.
出处 《四川医学》 CAS 2010年第6期744-746,共3页 Sichuan Medical Journal
关键词 肝硬化 腹水 癌抗原125 肿瘤标记 hepatic cirrhosis ascites cancer antigen 125 tumor marker
  • 相关文献

参考文献9

  • 1陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 2Collazos J,Genolla,Ruibal A.CA125 levels in patients with non-neoplastic liver diseases,a clinical and laboratory study[J].Scan J Clin Lab Invest,1992,52(3):201 -206.
  • 3洪光,刘维新,傅宝玉,史常山.肝硬化患者血清CA125水平的改变[J].世界华人消化杂志,2002,10(9):1072-1072. 被引量:30
  • 4童学成,郑中伟.血清CA125浓度与肝硬化患者腹水量关系的临床研究[J].中国现代医药杂志,2009,11(9):86-87. 被引量:3
  • 5Kovasc EJ,Messingham KA.Influence of alcohol and gender on immune response[J].Alcohol Res Health,2002,26 (4):257 - 263.
  • 6Pauler DK,Menon U,Mcintosh M,et al.Factors influencing serum CA125 Ⅱ levels in healthy postmenopausal women[J].Cancer Epidemiol Biomarkers Prev,2001,10(5):489-493.
  • 7Sch(o)niger-Hekele Maximilian,Müller C.The combined elevation of tumor markers CA 19-9 and CA125 in liver disease patients is highly specific for severe liver fibrosis[J].Dig Dis Sci,2006,51 (2):338 -345.
  • 8吴冬寒,麦子青.CA125在肝硬化腹水中的诊断价值[J].山东医药,2008,48(14):140-141. 被引量:5
  • 9Kalambokis G,Kostoula A,Economou M,et al.Tumor necrosis factoralpha-related intraperitoneal release of CA125 in cirrhotic patients with sterile ascites[J].Clin Chem,2005,51 (11):2207 - 2208.

二级参考文献14

  • 1王兰君,李国兴,王秀民.卵巢癌和胰腺癌患者血清CA125、CA199的水平相关分析[J].放射免疫学杂志,2007,20(1):68-69. 被引量:6
  • 2Miralles C,Oream M,Espana P,et al.Cancer antigen 125 associa-ted with multiple benign malignant pathologies.Ann Surg Oncol,2002,10(2):150.
  • 3Kovacs EJ,Messingham KA.Influence of alcohol and gender on immune response.Alcohol Res Health,2002,26:257-263.
  • 4Pauler DK,Menon U,Mcintosh M,et al.Factors influencing serum CA125 II levels in healthy postmenopausal women.Cancer Epid-emiol Biomarkers Prev,2001,10:489-493.
  • 5Devarhavi H,Kaese D,Williams AW,et al.Cancer antigen 125 in patients with chronic liver disease.Mayo Clin Proc,2002,77(6):538-541.
  • 6Zuckerman E,Lanir A,Sabo E,et al.Cancer antigen 125:a sensitive marker of ascites in patients with live cirrhosis.Am Gastroenteol,2001,96(1):253-254.
  • 7Kalambokis G,Kostoula A,EconomouM,et al.Tumor Necrosis Factor-alpha-Related intraperitoneal release of CA125 in cirrh-otic patientswith sterile ascites.Clin Chem,2005,51(11):2207-2208.
  • 8陈灏珠.实用内科学.12版.北京:人民卫生出版社,2005:866-868.
  • 9蔡东焱,陶敏,段卫明,王振欣,谢菁,冯军,王庆才.血清癌胚抗原、CA125、CA19-9测定对肺癌诊断及预后判断的价值[J].苏州大学学报(医学版),2007,27(4):558-561. 被引量:11
  • 10谢万昌,章菲菲.肝硬化患者检测血清CA125的临床意义[J].临床军医杂志,2008,36(2):227-228. 被引量:4

共引文献1845

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部